Novartis extends partnership with MorphoSys

12/3/2007 | Forbes · Wall Street Journal, The

Novartis AG announced it is signing a new agreement with German biotech firm MorphoSys AG, extending their alliance for 10 more years. The potential $1 billion collaborative deal will concentrate on developing antibody-based biological drugs for a wide range of diseases, and also allows Novartis exclusive access to MorphoSys's human antibody libraries.

View Full Article in:

Forbes · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX